Table 2 Relationship between Baseline and Procedural Characteristics with Post-TAVR Length of Stay, Adjusted by Model Covariates. Multivariable analysis of the variables associated with length of stay

 2014

Referent

 2012

0.78 (0.68–0.9)

<0.001

 2013

0.85 (0.73–0.98)

0.021

 Female

Referent

 Male

1.12 (0.97–1.3)

0.133

Age

0.99 (0.99–1)

<0.001

 0–2 days

Referent

  ≥ 3 days

0.64 (0.46–0.9)

0.009

BMI

1 (0.98–1.02)

0.920

STS Risk Score

0.98 (0.96–1)

0.064

 4

Referent

 1–2

1.28 (1.1–1.49)

0.001

 3

1.16 (1.03–1.31)

0.019

Atrial Fibrillation

0.76 (0.69–0.84)

<0.001

Hypertension

1 (0.83–1.2)

0.960

Diabetes Mellitus

1 (0.89–1.13)

0.986

Dyslipidemia

0.92 (0.68–1.24)

0.577

Coronary Artery Disease

0.98 (0.82–1.16)

0.805

Prior PCI

1.05 (0.84–1.31)

0.670

Prior Open Heart Surgery

1.15 (1.09–1.21)

<0.001

Dialysis

0.95 (0.64–1.41)

0.797

COPD

0.94 (0.75–1.17)

0.558

Peripheral Vascular Disease

1.01 (0.81–1.25)

0.948

Permanent Pacemaker

1.1 (0.74–1.62)

0.644

Stroke

0.81 (0.58–1.13)

0.215

Pre-Procedural Ejection Fraction (1ss0%)

1.05 (1.03–1.07)

<0.001

Pre-Procedural Mean Pressure Gradient

1 (1–1.01)

<0.001

Procedure Time (10 min)

0.98 (0.96–0.99)

0.001

 Transfemoral

Referent

 Direct Aortic

0.76 (0.67–0.85)

<0.001

 Subclavian or Suprasternal

2.42 (1.4–4.2)

0.002

 Transapical

0.49 (0.41–0.58)

<0.001

 General Anesthesia

Referent

 Local/Conscious Sedation

1.19 (1.06–1.35)

0.004

 Medtronic CoreValve or Evolut-R

Referent

 Edwards XT or S3

0.99 (0.96–1.03)

0.647

 Portico

0.43 (0.25–0.73)

0.002

Valve in Valve Procedure

1.28 (1.15–1.41)

<0.001

Procedure prior to Weekend^a

0.88 (0.77–1.01)

0.061